Description
Tirzepatide Research Peptide
Tirzepatide is a synthetic peptide supplied for controlled laboratory investigation. This compound, comprising 39 amino acids with a C-20 fatty diacid moiety, is studied for its dual GIP/GLP-1 receptor agonism. Its defined structure allows for repeatable studies under standardized conditions, enabling researchers to examine its specific interactions within biological systems and assess its impact on metabolic pathways.
Because of its capacity to activate both GIP and GLP-1 receptors, researchers value Tirzepatide for investigating the synergistic effects of dual incretin pathway activation. Studies in controlled environments examine its glucose-dependent insulinotropic signaling patterns, providing insights into its interaction behavior and compound-specific mechanisms within metabolic research models. This approach ensures data consistency across experiments and facilitates a deeper understanding of its biological role.
In laboratory settings, Tirzepatide is handled following standard peptide preparation and safety procedures. It is supplied as a lyophilized powder. For research applications, reconstitute with bacteriostatic water. After reconstitution, refrigerate at 2-8°C. For extended storage, the lyophilized powder should be stored in cool, dry conditions, and reconstituted solutions can be frozen at -20°C to maintain integrity for subsequent experiments.
This compound offers consistency in composition, making it compatible with structured research workflows that demand reduced variation. Its stable characteristics ensure suitability for long-term laboratory projects, allowing researchers to conduct precise investigations and generate reliable data for complex biological inquiries within controlled experimental frameworks.
Ongoing research includes Tirzepatide for its defined sequence and stable behavior. Its suitability for controlled research models facilitates detailed examination of glucose homeostasis, metabolic regulation, and the intricate signaling pathways involved in incretin hormone action.
Important Notice: Tirzepatide 100mg is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic research-grade peptide, classified as a dual GIP/GLP-1 receptor agonist. It consists of 39 amino acids and incorporates a C-20 fatty diacid moiety. Researchers utilize this compound in laboratory settings to investigate its defined mechanism of action involving dual incretin pathway activation within controlled experimental models. Its structural properties are precisely characterized for research purposes.
What is the structural significance of Tirzepatide’s C-20 fatty diacid moiety?
The C-20 fatty diacid moiety on Tirzepatide is a key structural modification. In research models, this moiety is hypothesized to contribute to its pharmacokinetic profile, potentially influencing its half-life and distribution. Scientists study this modification to understand its role in receptor binding affinity and overall compound stability, allowing for sustained investigation within experimental systems and consistent data collection.
What biological systems are studied using Tirzepatide?
Researchers primarily use Tirzepatide to study systems involved in metabolic regulation and glucose homeostasis. This includes investigations into pancreatic islet function, glucose uptake mechanisms in various tissues, and the interplay between gut hormones and systemic metabolism. Studies examine its effects on insulin secretion and glucagon suppression in controlled laboratory environments, contributing to an understanding of incretin pathways.
How does Tirzepatide’s dual agonism function in research models?
In research models, Tirzepatide functions as an agonist for both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual agonism is studied for its potential synergistic effects on glucose-dependent insulin secretion, inhibition of glucagon release, and gastric emptying modulation. Researchers examine these combined signaling patterns to understand their impact on metabolic pathways and physiological responses.
Why is Tirzepatide of interest in metabolic research?
Tirzepatide is of interest in metabolic research due to its unique dual GIP/GLP-1 receptor agonism. This mechanism offers a distinct approach for investigating complex metabolic pathways, particularly those related to glucose regulation and energy balance. Researchers value its defined action for studying incretin signaling and its implications in controlled laboratory settings, providing insights into metabolic physiology and potential therapeutic targets.
What are the recommended storage conditions for Tirzepatide for research use?
For optimal preservation of Tirzepatide as a research compound, the lyophilized powder should be stored in cool, dry conditions, typically below -20°C for long-term stability. Upon reconstitution with bacteriostatic water, the solution should be refrigerated at 2-8°C. For extended storage of reconstituted solutions, freezing at -20°C is recommended, ensuring compound integrity and consistent biological activity for repeatable experimental use.
Reviews
There are no reviews yet.